Cargando…
Strategic testing approaches for targeted disease monitoring can be used to inform pandemic decision-making
More than 1.6 million Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) tests were administered daily in the United States at the peak of the epidemic, with a significant focus on individual treatment. Here, we show that objective-driven, strategic sampling designs and analyses can maximi...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8241114/ https://www.ncbi.nlm.nih.gov/pubmed/34138840 http://dx.doi.org/10.1371/journal.pbio.3001307 |
_version_ | 1783715343327297536 |
---|---|
author | Nichols, James D. Bogich, Tiffany L. Howerton, Emily Bjørnstad, Ottar N. Borchering, Rebecca K. Ferrari, Matthew Haran, Murali Jewell, Christopher Pepin, Kim M. Probert, William J. M. Pulliam, Juliet R. C. Runge, Michael C. Tildesley, Michael Viboud, Cécile Shea, Katriona |
author_facet | Nichols, James D. Bogich, Tiffany L. Howerton, Emily Bjørnstad, Ottar N. Borchering, Rebecca K. Ferrari, Matthew Haran, Murali Jewell, Christopher Pepin, Kim M. Probert, William J. M. Pulliam, Juliet R. C. Runge, Michael C. Tildesley, Michael Viboud, Cécile Shea, Katriona |
author_sort | Nichols, James D. |
collection | PubMed |
description | More than 1.6 million Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) tests were administered daily in the United States at the peak of the epidemic, with a significant focus on individual treatment. Here, we show that objective-driven, strategic sampling designs and analyses can maximize information gain at the population level, which is necessary to increase situational awareness and predict, prepare for, and respond to a pandemic, while also continuing to inform individual treatment. By focusing on specific objectives such as individual treatment or disease prediction and control (e.g., via the collection of population-level statistics to inform lockdown measures or vaccine rollout) and drawing from the literature on capture–recapture methods to deal with nonrandom sampling and testing errors, we illustrate how public health objectives can be achieved even with limited test availability when testing programs are designed a priori to meet those objectives. |
format | Online Article Text |
id | pubmed-8241114 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-82411142021-07-12 Strategic testing approaches for targeted disease monitoring can be used to inform pandemic decision-making Nichols, James D. Bogich, Tiffany L. Howerton, Emily Bjørnstad, Ottar N. Borchering, Rebecca K. Ferrari, Matthew Haran, Murali Jewell, Christopher Pepin, Kim M. Probert, William J. M. Pulliam, Juliet R. C. Runge, Michael C. Tildesley, Michael Viboud, Cécile Shea, Katriona PLoS Biol Essay More than 1.6 million Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) tests were administered daily in the United States at the peak of the epidemic, with a significant focus on individual treatment. Here, we show that objective-driven, strategic sampling designs and analyses can maximize information gain at the population level, which is necessary to increase situational awareness and predict, prepare for, and respond to a pandemic, while also continuing to inform individual treatment. By focusing on specific objectives such as individual treatment or disease prediction and control (e.g., via the collection of population-level statistics to inform lockdown measures or vaccine rollout) and drawing from the literature on capture–recapture methods to deal with nonrandom sampling and testing errors, we illustrate how public health objectives can be achieved even with limited test availability when testing programs are designed a priori to meet those objectives. Public Library of Science 2021-06-17 /pmc/articles/PMC8241114/ /pubmed/34138840 http://dx.doi.org/10.1371/journal.pbio.3001307 Text en https://creativecommons.org/publicdomain/zero/1.0/This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 (https://creativecommons.org/publicdomain/zero/1.0/) public domain dedication. |
spellingShingle | Essay Nichols, James D. Bogich, Tiffany L. Howerton, Emily Bjørnstad, Ottar N. Borchering, Rebecca K. Ferrari, Matthew Haran, Murali Jewell, Christopher Pepin, Kim M. Probert, William J. M. Pulliam, Juliet R. C. Runge, Michael C. Tildesley, Michael Viboud, Cécile Shea, Katriona Strategic testing approaches for targeted disease monitoring can be used to inform pandemic decision-making |
title | Strategic testing approaches for targeted disease monitoring can be used to inform pandemic decision-making |
title_full | Strategic testing approaches for targeted disease monitoring can be used to inform pandemic decision-making |
title_fullStr | Strategic testing approaches for targeted disease monitoring can be used to inform pandemic decision-making |
title_full_unstemmed | Strategic testing approaches for targeted disease monitoring can be used to inform pandemic decision-making |
title_short | Strategic testing approaches for targeted disease monitoring can be used to inform pandemic decision-making |
title_sort | strategic testing approaches for targeted disease monitoring can be used to inform pandemic decision-making |
topic | Essay |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8241114/ https://www.ncbi.nlm.nih.gov/pubmed/34138840 http://dx.doi.org/10.1371/journal.pbio.3001307 |
work_keys_str_mv | AT nicholsjamesd strategictestingapproachesfortargeteddiseasemonitoringcanbeusedtoinformpandemicdecisionmaking AT bogichtiffanyl strategictestingapproachesfortargeteddiseasemonitoringcanbeusedtoinformpandemicdecisionmaking AT howertonemily strategictestingapproachesfortargeteddiseasemonitoringcanbeusedtoinformpandemicdecisionmaking AT bjørnstadottarn strategictestingapproachesfortargeteddiseasemonitoringcanbeusedtoinformpandemicdecisionmaking AT borcheringrebeccak strategictestingapproachesfortargeteddiseasemonitoringcanbeusedtoinformpandemicdecisionmaking AT ferrarimatthew strategictestingapproachesfortargeteddiseasemonitoringcanbeusedtoinformpandemicdecisionmaking AT haranmurali strategictestingapproachesfortargeteddiseasemonitoringcanbeusedtoinformpandemicdecisionmaking AT jewellchristopher strategictestingapproachesfortargeteddiseasemonitoringcanbeusedtoinformpandemicdecisionmaking AT pepinkimm strategictestingapproachesfortargeteddiseasemonitoringcanbeusedtoinformpandemicdecisionmaking AT probertwilliamjm strategictestingapproachesfortargeteddiseasemonitoringcanbeusedtoinformpandemicdecisionmaking AT pulliamjulietrc strategictestingapproachesfortargeteddiseasemonitoringcanbeusedtoinformpandemicdecisionmaking AT rungemichaelc strategictestingapproachesfortargeteddiseasemonitoringcanbeusedtoinformpandemicdecisionmaking AT tildesleymichael strategictestingapproachesfortargeteddiseasemonitoringcanbeusedtoinformpandemicdecisionmaking AT viboudcecile strategictestingapproachesfortargeteddiseasemonitoringcanbeusedtoinformpandemicdecisionmaking AT sheakatriona strategictestingapproachesfortargeteddiseasemonitoringcanbeusedtoinformpandemicdecisionmaking |